Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Utility of CTCA in CTO PCI
Author(s): Firas Yassin , Jawad Khan , Abdul Mozid , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Coronary Physiology and DCBs: The Modern Approach for CTO-PCI
Author(s): Roberto Garbo , , , et al Start date: Jun 03, 2024
Join us for a transformative broadcast, chaired by Dr Tomáš Kovárník (Charles University, Prague, CZ), showcasing the latest advancements in CTO PCI procedures with state-of-the-art technology.Investigate the possibility of shortening stent lengths with precision physiology guidance, featuring Dr Mohamed Ayoub's (University Heart Center NRW, Bad Oeynhausen, DE) presentationExplore the combination… View more

Imaging & Diagnostics

Intervention
Updates on Chronic Coronary Syndrome
Author(s): Filippo Gurgoglione , Giampaolo Niccoli Added: 5 months ago

Prevention & Chronic Conditions

CV Disease in Special Populations
A Preferred Substrate-based Nomenclature in Myocardial Ischaemic Syndromes
Author(s): William E Boden , Juan Carlos Kaski , C Noel Bairey Merz , et al Added: 2 weeks ago

MI/ACS
Job title: Interventional Cardiologist
DrGasparini is an Interventional Cardiologist atHumanitas Research Hospital, Italy. He is specialized in treatment of complex coronary artery disease, such as chronic total occlusions, saphenous vein grafts, bifurcations, left main disease and in management of complications.He is CTO operator, proctor and educator. He is the Founder and Course Director of the CTO Live Aid event. Dr… View more
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 6 months ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Percutaneous Left Atrial Appendage Occlusion
Author(s): Pierluigi Merella , Giuseppe Talanas , Giovanni Lorenzoni , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Intervention
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 1 year ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
Research Area(s) / Expertise:
Dr Ali is a board-certified cardiologist specialising in interventional and structural cardiology atSt Francis Hospital and Heart Centerin Roslyn, New York. Ziad is an internationally renowned expert in complex high-risk indicated percutaneous coronary interventions (CHIP) including the treatment of chronic total occlusions (CTO) where the arteries in the heart become completely blocked. … View more